Fulcrum Therapeutics to Participate at the Cantor Virtual Muscular Dystrophy Symposium
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to participate in a fireside chat at the Cantor Virtual Muscular Dystrophy Symposium on April 2, 2024. The Company focuses on developing small molecules for rare genetic diseases.
03/28/2024 - 04:05 PM
CAMBRIDGE, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the Cantor Virtual Muscular Dystrophy Symposium, being held on Tuesday, April 2, 2024 at 10:40 a.m. ET.
The webcast of the presentation will be accessible here and by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations . A replay of the webcast will be available on Fulcrum Therapeutics’ website for at least 30 days following the presentation.
About Fulcrum Therapeutics
Contact:
When will Fulcrum Therapeutics participate in the fireside chat at the Cantor Virtual Muscular Dystrophy Symposium?
Fulcrum Therapeutics will participate in the fireside chat on Tuesday, April 2, 2024, at 10:40 a.m. ET.
What is the focus of Fulcrum Therapeutics as a company?
Fulcrum Therapeutics focuses on developing small molecules to improve the lives of patients with genetically defined rare diseases.
Where can the webcast of the presentation be accessed?
The webcast of the presentation can be accessed on Fulcrum Therapeutics' website at https://ir.fulcrumtx.com/events-and-presentations.
How long will the replay of the webcast be available?
The replay of the webcast will be available on Fulcrum Therapeutics' website for at least 30 days following the presentation.
FULC Rankings
#4442 Ranked by Stock Gains
FULC Stock Data
Industry
Medicinal and Botanical Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Manufacturing, Medicinal and Botanical Manufacturing
About FULC
what if we could regulate genes, not just discover them? what if we could treat disease at their genetic source? what if we could integrate multiple disciplines to develop breakthrough medicines? what if you could be a part of a passionate team committed to the patients we serve? we can. we will. we are. join us. we are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. a fulcrum is defined as the point on which a lever rests, balances and pivots. fulcrum therapeutics is intervening in gene regulatory mechanisms to unlock the information contained in the human genome. the fulcrum product engine is dedicated to bringing balance to the genetic on and off switches in disease. our approach the sequencing of the human genome has provided incredible insight into disease biology, yet the richness of biology comes from the dynamic on and off switches that control the genome – gene regulation. the fulcrum product eng
